+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori



The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori



Alimentary Pharmacology & Therapeutics 14(7): 893-900



Background: Antibiotic resistance affects the success of anti-Helicobacter pylori therapies and varies greatly from country to country. Aim: To compare the efficacy of three short-term triple regimens in relation to H. pylori primary resistance in our region. Methods: We enrolled 210 H. pylori-positive dyspeptic patients for this randomized, open, parallel-group study. Three arms of 70 patients each received the following 1-week regimens: (1) rantidine bismuth citrate 400 mg b.d. + clarithromycin 250 mg b.d. + metronidazole 500 mg b.d. (RCM); (2) bismuth subcitrate 240 mg b.d. + amoxycillin 1000 mg b.d. + metronidazole 500 mg b.d. (BAM); (3) omeprazole 20 mg o.d. + clarithromycin 250 mg b.d. + metronidazole 500 mg b.d. (OCM). H. pylori was assessed by CLO-test and histology before and 4 weeks after therapy. Antibiotic resistance was assessed by E-test. Results: On intention-to-treat analysis RCM was more effective than OCM (84% vs. 69%; P < 0.03) and BAM (84% vs. 63; P < 0.004). MIC determination was successful in 117 out of 210 patients (55%); metronidazole resistance was present in 52 out of 117 patients (44%) and clarithromycin resistance was present in 17 out of 117 patients (14%). Excellent cure rates were achieved when strains were sensitive to both antibiotics (100% with RCM and BAM and 90% with OCM), whereas RCM was superior to OCM (P = 0.009) and BAM (P = 0.001) with respect to overall resistant strains (94% vs. 57% and 38%, respectively). Conclusions: One-week RCM is the best regimen to eradicate H. pylori in our geographical area. This seems to be linked to the better ability of RCM compared to OCM and BAM in overcoming the high prevalence of H. pylori resistance to both metronidazole and clarithromycin in our region.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011514241

Download citation: RISBibTeXText

PMID: 10886045

DOI: 10.1046/j.1365-2036.2000.00780.x


Related references

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules 20(4): 6068-6092, 2015

Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients. Tropical Doctor 33(4): 225-228, 2003

Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. American Journal of Gastroenterology 93(10): 1909-1913, 1998

Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens. Clinical Microbiology and Infection 8(9): 598-603, 2002

The impact of anticiotic resistance on the efficacy of three 7-day regimens against H pylori infection. Gastroenterology 116(4 Part 2): A302-A303, 1999

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 13(3): 297-302, 1999

Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens. Zhonghua Yi Xue Za Zhi 86(38): 2679-2682, 2006

Infection with Helicobacter pylori. Prevalence, research and impact of antibiotic resistance. Revista Espanola de Enfermedades Digestivas 101(11): 743-756, 2009

First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. Alimentary Pharmacology & Therapeutics 21(6): 773-782, 2005

Helicobacter  pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy. Gastroenterology Research and Practice 2012: 757926, 2012

Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance. Journal of Digestive Diseases 11(5): 313-318, 2010

Antibiotic resistance of Helicobacter pylori in children and macrolide-resistant genotypes in Helicobacter pylori. Zhonghua Yi Xue Za Zhi 94(8): 563-566, 2014

Re: Van der Wouden et al.: the influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens. American Journal of Gastroenterology 95(6): 1590-1591, 2000